Intramyocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial (2024)
Attributed to:
Pre-clinical In-vivo Functional Imaging for Translational Regenerative Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcvm.2024.1427023
Publication URI: http://dx.doi.org/10.3389/fcvm.2024.1427023
Type: Journal Article/Review
Parent Publication: Frontiers in Cardiovascular Medicine